Discussions highlight key results such as a vaccine efficacy of around 80% against symptomatic dengue, with mentions of the vaccine’s potential to prevent severe disease across all serotypes. The tone is optimistic, using words like ‘exciting,’ ‘huge,’ and phrases like ‘can save so many lives,’ which demonstrate enthusiasm and recognition of the vaccine’s significance in controlling dengue.
AgreementModerate agreement
Most discussions express strong support and recognition of the vaccine’s efficacy and potential impact, highlighting positive trial results.
InterestHigh interest
Many discussions emphasize the significance of this development, indicating high interest in the vaccine’s implications.
EngagementHigh engagement
Posts frequently include detailed summaries, comparisons with other vaccines, and calls to action, reflecting deep engagement.
ImpactHigh impact
The widespread acknowledgment of the vaccine's potential to reduce dengue cases and save lives demonstrates its high perceived impact.
Abstract in brief
The ButantanDengue Vaccine (BRButantanDengueDV) is an experimental single-dose vaccine designed to protect against all four dengue virus serotypes, and a phase 3 trial in Brazil aims to evaluate its effectiveness and safety over a 2-year period among children and adults.
The trial included over 16,200 participants across different age groups, comparing the vaccine to a placebo, and measured outcomes such as reduction in symptomatic dengue cases and adverse events within 21 days post-vaccination.
Results showed an overall vaccine efficacy of around 79-89% depending on prior dengue exposure and age group, with particularly high effectiveness against DENV1 and DENV2 serotypes, supporting its potential as a dengue prevention tool pending further data.]
Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editorial: Three Dengue Vaccines — What Now? https://t.co/T4cZWceXDX
#Pediatrics https://t.co/6kAqPLkfAr
Feb 1, 2024 · 135 likes · 44 shares · 931,905 followersView post →
DA
Dr. Akhil
@DrAkhilX · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
https://t.co/qZbjO7rwTk https://t.co/mGMNZJg2gX
Dec 17, 2024 · 55 likes · 3 shares · 43,570 followersView post →
DK
Dr Ahmad Rehan Khan
@AhmadRehanKhan · X
Dengue Vaccine:
Great News For Pakistani
Mar 3, 2024 · 45 likes · 10 shares · 21,275 followersView post →
CF
Conrad Fischer
@SeeFisch · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/HwTqPgQOET
Mar 3, 2024 · 33 likes · 4 shares · 102,418 followersView post →
W
WorldDengueDay
@WorldDengueDay · X
A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic country (evaluated in children & adults). The vaccine offers protection against 4 serotypes of DENV. The study by @butantanoficial in @NEJM: https://t.co/umMC82qkG0 https://t.co/lKcr9XfonR
Mar 11, 2024 · 29 likes · 16 shares · 2,407 followersView post →
N
NEJM
@NEJM · X
2. Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb #InfectiousDisease https://t.co/xvyIFFcIEE
Feb 10, 2024 · 24 likes · 7 shares · 931,905 followersView post →
The Butantan-Dengue Vaccine is an experimental single-dose vaccine protecting against all four dengue serotypes. A phase 3 trial involving over 16,200 participants evaluated its safety and effectiveness, showing…
3-year enrollment,16,235 participants: Butantan-DV. overall 2-year VE was 79.6% no prev dengue exposure; 89.2% exposure. VE was 80.1% in 2-6yrs, 77.8% in 7-17yrs, 90.0% in 18-59yrs. VE against DENV-1 was 89.5%; DENV-2 was 69.6%. DENV-3, DENV-4 not detected https://t.co/07R4JzJkTD
Sep 29, 2025 · 1 like · 34,662 followersView post →
V
@vasculitides
@vasculitides.bsky.social · Bluesky
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 11, 2025 · 51 shares · 13 followersView post →
FR
Fernando Reis
@fmreis · X
Among the highlights, a remarkable Brazilian study: "Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults" https://t.co/Ubre293KtA
RT @DrAkhilX: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
https://t.co/qZbjO7rwTk https://t.co/mGMNZJg2gX
Dec 18, 2024 · 3 shares · 900 followersView post →
MM
Mosso-Pani MA
@halfbloomprince · X
RT @DrAkhilX: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
https://t.co/qZbjO7rwTk https://t.co/mGMNZJg2gX
Dec 18, 2024 · 3 shares · 229 followersView post →
SM
Sanal MG
@sanalmg · X
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Women.
Overall Survival with Pembrolizumab in Early-Stage Triple -ve Br CA
Zdroj (2/3):Siqueira, A. M., Barral, A., . . . Nogueira, M. L. (2024). Live, attenuated, tetravalent Butantan–Dengue vaccine in children and adults. The New England Journal of Medicine, 390(5), 397–408. https://t.co/xKPLAjlcuM
DENGUE: Good news on dengue (description of disease below) - Single dose of Butantan-DV prevented symptomatic DENV-1 (90%) and DENV-2 (70%), regardless of dengue serostatus at baseline, through 2 years https://t.co/9ImFbl6CYB https://t.co/5bQGTBqS93
RT @SEIMC_: #DivulgaciónSEIMC: Ensayo fase 3 demuestra seguridad favorable y eficacia en adultos y niños de Butantan-DV en la prevención de…
Mar 15, 2024 · 3 shares · 1,944 followersView post →
S
SEIMC
@SEIMC_ · X
#DivulgaciónSEIMC: Ensayo fase 3 demuestra seguridad favorable y eficacia en adultos y niños de Butantan-DV en la prevención de #dengue sintomático por DENV-1 y DENV-2, independientemente de la exposición previa al dengue
Mar 14, 2024 · 14 likes · 3 shares · 24,132 followersView post →
AM
AgBk, MD
@agobk · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 193 followersView post →
NU
Neglected Global Diseases Initiative at UBC
@NGDIUBC1 · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 1,475 followersView post →
CD
Canadian Network for Neglected Tropical Diseases
@Can_NTDs · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 3,063 followersView post →
DM
Diego Morales
@diegomoralesvit · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 522 followersView post →
DE
Denis Escobar
@dnis77 · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 245 followersView post →
DL
D'Ombre et de Lumière
@louvetou · X
RT @WorldDengueDay: A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic count…
Mar 11, 2024 · 16 shares · 132 followersView post →
W
WorldDengueDay
@WorldDengueDay · X
A single-dose vaccine for #dengue shows 79.6% efficacy in phase 3 clinical trials conducted in Brazil, an endemic country (evaluated in children & adults). The vaccine offers protection against 4 serotypes of DENV. The study by @butantanoficial in @NEJM: https://t.co/umMC82qkG0 https://t.co/lKcr9XfonR
Mar 11, 2024 · 29 likes · 16 shares · 2,407 followersView post →
VB
Vinícius Borges
@DoutorMaravilha · X
https://t.co/ok6Mtf3F1x
Mar 10, 2024 · 11 likes · 138,396 followersView post →
CM
Claire_Sophia~MAGA
@MAGA231545 · X
RT @NEJM: 2. Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb #Infect…
Mar 3, 2024 · 45 likes · 10 shares · 21,275 followersView post →
D
DoctorTro
@DoctorTro · X
@SeeFisch Rather than ruin their day, let’s evaluate reasons why the COVID vaccine that is widely recommended still doesn’t have 2 year data and the planned 5 year placebo controlled data that Dengue does? It’s unacceptable IMVHO. Does that make me anti-vax?
Mar 3, 2024 · 5 likes · 1 share · 163,070 followersView post →
CF
Conrad Fischer
@SeeFisch · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/HwTqPgQOET
Mar 3, 2024 · 33 likes · 4 shares · 102,418 followersView post →
N
Nefertiti
@ReloadNefertiti · X
RT @JeremyFarrar: Live, Attenuated, Tetravalent Dengue Vaccine in Children and Adults https://t.co/9TCXlICiEv
https://t.co/Le53fIff3E
"A single dose of Butantan-DV prevented symptomatic DENV-1 and DENV-2, regardless of dengue serostatus at baseline, through 2 years of follow-up."
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults #MECFS #LongCovid
https://t.co/Le53fIff3E
Feb 26, 2024 · 1 like · 3,987 followersView post →
A
Andrea
@AndreaJArrati · X
RT @LaMicroMola: Buenas noticias con la vacuna del #Dengue Butantan. La fase 3 muestra cerca del 80% de protección sintomática hasta dos añ…
Feb 22, 2024 · 17 shares · 6,349 followersView post →
EC
EntomoNews Bernadette Cassel
@collemyria · X
Les vaccins se font une place dans le combat contre la dengue
https://t.co/oQvDwtKiMU
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM
via Le Monde
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 33 followersView post →
N
Ncontsi
@ncontsi · X
@brasildefato_en Random question: Could you tell us more about the exciting development of the dengue vaccine produced by the Butantan Institute in the state of São Paulo, which, according to the NEJM, prevents the development of the disease in 79.6% of those vaccinated?
https://t.co/NPgNINovAK
Feb 22, 2024 · 1 like · 1,251 followersView post →
FO
Fernando Bernal Ortiz
@fernando_bernal · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 829 followersView post →
R
Rafalimumab
@rafaMalaver · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 654 followersView post →
AR
Adriana Rojas
@dra_vancomicina · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 207 followersView post →
C
Cristian
@MDveter · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 604 followersView post →
JV
Javier de la Vega
@fjdelavegaolias · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 22, 2024 · 51 shares · 308 followersView post →
RM
R David M
@RayMolinaL · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 601 followersView post →
AO
Alejandro Jose Agresoth De La Ossa
@alejoagresoth · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 31 followersView post →
RM
Rubén Sánchez Mendoza
@RubnSm · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 577 followersView post →
F
FelixGM
@FeG_MO · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 1,513 followersView post →
EM
Eve, MD
@EveMejia0507 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 193 followersView post →
VH
Victor Hernández
@VicHdez27 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 142 followersView post →
WC
Walter Campos
@wcampos731 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 356 followersView post →
M
Marina
@navy_30 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 30 followersView post →
B
BizarrMD
@DrAntonioSilva1 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 321 followersView post →
CH
Caroline Huaman
@marussiah · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 200 followersView post →
AC
Ana Caro
@interlista · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 88 followersView post →
GR
Gonzalo Rivera
@AcinetoRiver · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 485 followersView post →
JE
J. Vicente Esteban
@Vicenvallaurg1 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 1,237 followersView post →
XF
Xavier Anzueto Fernández
@XaviAF22 · X
RT @infeccHRUmalaga: El #Dengue causa millones de casos y >40.000 muertes/año ☠️. En @NEJM NUEVA VACUNA
Feb 21, 2024 · 51 shares · 75 followersView post →
MG
Maria Gonçalves
@Maria_CBG · X
RT @NEJM: 2. Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb #Infect…
Feb 15, 2024 · 7 shares · 122 followersView post →
AJ
Aaron Molina Jaimes
@AaMolinaID · X
Una sola dosis de vacuna vs #Dengue (Butantan) en un estudio bien diseñado ( y aún corriendo) en
@CamiloPrietoVal A propósito Dr. Prieto... Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/aXmKMlCoAe
Three Dengue Vaccines — What Now? https://t.co/gWJgdLighk
RT @NEJM: 2. Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb #Infect…
Feb 10, 2024 · 7 shares · 630 followersView post →
N
NEJM
@NEJM · X
2. Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb #InfectiousDisease https://t.co/xvyIFFcIEE
Feb 10, 2024 · 24 likes · 7 shares · 931,905 followersView post →
A
ARYAN®
@gladeolie · X
#Live, #Attenuated, #Tetravalent #Butantan–#Dengue #Vaccine in #Children and #Adults in #Children and Adults | SOMEONE SOMEWHERE (https://t.co/JnxfQijdu0)
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/NHIIKidR9Y
Feb 6, 2024 · 2 likes · 1,700 followersView post →
TS
Top Biomedical Science
@imedverse · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
@NEJM #MedEd #dengue
https://t.co/FxNAlQickW https://t.co/ksIsBaUOoG
Feb 5, 2024 · 5 likes · 90,252 followersView post →
EA
EARLの医学&AIノート
@EARL_med_tw · X
Feb 4, 2024 · 7 likes · 148,818 followersView post →
AP
Antonio M Quispe, MD, PhD
@drantonioquispe · X
Aquí les dejo en enlace al estudio y aprovecho para invitarlos a seguirme en mi página de Facebook!
https://t.co/USf0CYYjHf
Feb 4, 2024 · 9 likes · 1 share · 30,550 followersView post →
BL
Beatriz H León
@BeatrizHLeon · X
Dosis d Butantan-DV-vacuna tetravalente viva atenuada-contra dengue, previno la enf sintomática durante seguimiento 2años, en estudio fase III control/placebo,Brasil
Eficacia d casi 80%en prevención dengue sintomático, 89.2%eficacia en los enfermaron antes https://t.co/sKYBDJgeEH
Según Kallás y col., una dosis única de Butantan-DV previno el DENV-1 y el DENV-2 sintomáticos, durante 2 años de seguimiento.
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/hu8IJRYBJF
Feb 4, 2024 · 5 likes · 4 shares · 2,062 followersView post →
P
Pripsil_
@Pripsil_ · X
RT @estercsabino: https://t.co/ZhVddjyp5C
Feb 3, 2024 · 1 share · 2,114 followersView post →
DM
Daniel Munhoz
@DMunhoz · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 3, 2024 · 44 shares · 374 followersView post →
HM
Héctor J. Lora Rodríguez, MD
@hectorjoselora · X
RT @CarlosdelRio7: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults @NEJM https://t.co/W1JWYqOBZX A single dose…
RT @CarlosdelRio7: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults @NEJM https://t.co/W1JWYqOBZX A single dose…
Feb 3, 2024 · 2 shares · 2,525 followersView post →
CR
Carlos del Rio
@CarlosdelRio7 · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults @NEJM https://t.co/W1JWYqOBZX A single dose of Butantan-DV prevented symptomatic DENV-1 and DENV-2, regardless of dengue serostatus at baseline, through 2 years of follow-up.
Feb 3, 2024 · 9 likes · 2 shares · 55,659 followersView post →
A
ARYAN®
@gladeolie · X
#Live, #Attenuated, #Tetravalent #Butantan–#Dengue #Vaccine in #Children and #Adults | SOMEONE SOMEWHERE (https://t.co/JnxfQijLjy)#
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 1,480 followersView post →
MC
Martin Correa
@martinrafco · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 235 followersView post →
LG
Luis Fernando Gómez Gutiérrez.
@LuisFernandoGm6 · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 1,726 followersView post →
ナフ
ナカイサヤカ＠フル
@sayakatake · X
RT @carpe_diem0820: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
ブラジルのブタンタン研究所（Instituto Butantan）によって開発され…
Feb 1, 2024 · 4 shares · 12,212 followersView post →
C
_clara_
@_clara_ · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 282 followersView post →
S
Samuel
@samu_gab · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 601 followersView post →
PR
Pablo Martínez-Rojas
@_elmicrobito · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 523 followersView post →
EC
Ezeonufo Chukwunonso
@Ezeonufo · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 1,359 followersView post →
LM
Luigi que não é o irmão do Mario
@luigiadler · X
RT @NEJM: Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editoria…
Feb 1, 2024 · 44 shares · 115 followersView post →
N
NEJM
@NEJM · X
Original Article: Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults https://t.co/YY0iRP2Xqb
Editorial: Three Dengue Vaccines — What Now? https://t.co/T4cZWceXDX
#Pediatrics https://t.co/6kAqPLkfAr
Feb 1, 2024 · 135 likes · 44 shares · 931,905 followersView post →
GO
Global Health Observ
@GlobalPHObserv · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/lNVMVmbfxP
Feb 1, 2024 · 3 likes · 2 shares · 6,553 followersView post →
F
ForensicPsyMD
@ForensicPsyMD · X
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/CZf6fb7Twj
Protección contra el dengue grave : Revista Pesquisa Fapesp
News
... 10.1056/NEJMoa2301790?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed" target="_blank" rel="noopener">The New England ...
Butantan vaccine candidate reduces the risk of severe dengue fever ...
News
... 10.1056/NEJMoa2301790?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed" target="_blank" rel="noopener">The New England ...
Candidata a vacina do Butantan reduz em 89% o risco dengue ...
News
... 10.1056/NEJMoa2301790?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed" target="_blank" rel="noopener">The New England ...
The Health of Nations | PDF | Messenger Rna | Food Security
News
Butantan-Dengue Vaccine in Children and Adults. New England J Med. 2024 February 1; 390(5):397-408. doi: 10.1056/NEJMoa2301790. PMID: 38294972. Europe is ...
Ela atua diretamente nos circuitos cerebrais responsáveis por movimento, dor, emoções e controle corporal. No vídeo, você verá como utilizamos tecnologia ...
#pesquisa Pesquisadores da UFF - Universidade Federal ...
Facebook
O estudo, publicado no New England Journal of Medicine (https://www.nejm. org/doi/full/10.1056/NEJMoa2301790) foi conduzido entre 2016 e 2024, tendo entre seus ...
org/doi/full/10.1056/NEJMoa2301790) foi conduzido entre 2016 e 2024, tendo entre seus autores vários imunologistas associados à Sociedade Brasileira de ...
Nejmoa2301790 Research-Summary | PDF | Vaccines | Immunology
News
Live, Attenuated, Tetravalent Butantan–Dengue Vaccine. in Children and Adults Kallás EG et al. DOI: 10.1056/NEJMoa2301790. Clinical Problem DENV serotypes ...
N
DA
DK
CF
W
PB
NC
FR
KG
MM
SM
BB
GR
KF
J
DK
CS
VZ
MM
VL
S
Sシ
JV
MS
J
S
AM
NU
CD
DM
DE
DL
VB
CM
SC
M
A
SK
AF
M
AM
EM
O
F
IM
M
AA
PP
MJ
SU
HN
D
N
BP
ID
JF
MS
CV
Y
RS
A
EC
H
N
FO
R
AR
C
JV
RM
AO
RM
F
EM
VH
WC
M
B
CH
AC
GR
JE
XF
MG
AJ
H
CD
DP
JR
FM
A
A
S
Z
RS
TS
EA
AP
BL
S
GS
D
P
DM
HM
DH
CR
AD
린
ト
RO
H
วท
LE
JM
KG
CE
MH
AO
JR
SN
ED
EK
GD
DJ
GK
M
平
CG
DS
DM
MD
EJ
FS
GW
OM
AB
AM
HS
JP
RY
CP
SP
AP
AM
CS
MF
MC
LG
ナフ
C
S
PR
EC
LM
GO
F
SL
JM
ES